Japanese Oil and Gas Stock News

TSE:7453
TSE:7453Multiline Retail

Why Ryohin Keikaku (TSE:7453) Is Up 6.2% After Record H1 Results, Outlook Hike And Stock Split

In a board meeting held on April 10, 2026, Ryohin Keikaku announced record first-half revenue and profit growth, raising its full-year earnings outlook and annual dividend forecast while implementing a 2-for-1 stock split. The company linked its upgraded guidance and higher dividend to strong overseas performance, margin improvement, and the earnings impact of yen weakness, underscoring management’s emphasis on stable shareholder returns. We’ll now examine how Ryohin Keikaku’s upgraded...
TSE:4203
TSE:4203Chemicals

A Look At Sumitomo Bakelite (TSE:4203) Valuation After Its Higher Year-End Dividend Guidance

Dividend revision and board meeting put Sumitomo Bakelite (TSE:4203) in focus Sumitomo Bakelite (TSE:4203) has drawn fresh attention after revising year end dividend guidance to ¥60.00 per share for the fiscal year ending March 31, 2026, up from ¥55.00. On the same March 30, 2026 date, the company also convened a board meeting to consider nominating an additional director, adding a corporate governance angle to the dividend update. See our latest analysis for Sumitomo Bakelite. At a share...
TSE:2160
TSE:2160Biotechs

GNI Group (TSE:2160) Valuation In Focus As 2026 Earnings Forecasts Sharpen Growth Outlook

Fresh guidance puts GNI Group’s 2026 revenue outlook in focus GNI Group (TSE:2160) has issued consolidated earnings guidance for the fiscal year ending December 31, 2026, projecting revenue of ¥27,158 million. This gives investors a clearer benchmark for assessing the current share price. See our latest analysis for GNI Group. The share price, now at ¥3,140, has eased slightly over the past day but still carries strong momentum. It has a 90 day share price return of 23.57% and a 1 year total...
TSE:8136
TSE:8136Specialty Retail

April 2026's Global Stocks That May Be Trading Below Estimated Value

As global markets rally on improved sentiment following a U.S.-Iran ceasefire agreement, investors are taking note of the positive momentum in major indices, particularly driven by advancements in technology and consumer discretionary sectors. Amid this environment of cautious optimism, identifying stocks that may be undervalued can provide opportunities for those looking to capitalize on potential market inefficiencies.
TSE:4980
TSE:4980Electronic

3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 45.4%

As Asian markets navigate the complexities of geopolitical tensions and fluctuating commodity prices, investors are keenly observing opportunities for value amid broader market shifts. In this environment, identifying undervalued stocks that may be trading at significant discounts can provide a strategic advantage, especially when these stocks possess strong fundamentals and growth potential in sectors poised to benefit from easing tensions and stabilizing economic conditions.
TSE:3405
TSE:3405Chemicals

3 Dividend Fortresses With 5% Yields And Quiet Margin And ROE Upside

With inflation pressures flaring up again through energy prices, bond yields staying sensitive to every macro headline, and consumer confidence under strain, dependable income has rarely looked more valuable. That is where the Dividend Fortresses screener comes in. It focuses on rare 5%+ dividend yield stocks that aim to pair generous payouts with staying power through market storms. In this article, you will see three of the strongest names from that universe, along with clear, plain-English...
TSE:8697
TSE:8697Capital Markets

Assessing Japan Exchange Group (TSE:8697) Valuation After New Common Data Platform Initiative

Japan Exchange Group (TSE:8697) is back in focus after subsidiary JPX Market Innovation & Research and Japan Securities Finance agreed to jointly advance a common data platform for automating securities back-office processes. See our latest analysis for Japan Exchange Group. The stock’s latest share price of ¥1,948.5 comes after a 1-day share price return of 1.43% and a 7-day return of 3.29%. The 1-year total shareholder return of 34.26% and 3-year total shareholder return of 102.38% point to...
TSE:3608
TSE:3608Luxury

TSI Holdings (TSE:3608) Margin Compression To 2.3% Tests Bullish Growth Narratives

TSI HoldingsLtd (TSE:3608) has wrapped up FY 2026 with fourth quarter revenue of ¥50.5b and basic EPS of ¥8.73, set against trailing twelve month revenue of ¥167.1b and EPS of ¥60.47 that frame the full year picture. The company has seen quarterly revenue range from ¥30.6b to ¥50.5b across FY 2026, with basic EPS moving between a loss of ¥10.02 and a high of ¥33.81 over the same stretch. This provides investors with a clearer view of how earnings have moved around the headline growth...
TSE:7741
TSE:7741Medical Equipment

HOYA Weighs Stock Split As Valuation Premium And Momentum Converge

HOYA, listed as TSE:7741, is considering a stock split or other measures to reduce its investment unit. The company aims to make its shares more accessible to a broader range of investors. Plans have not yet been finalized, so the outcome and timing of any change remain undecided. HOYA operates across optics related fields, including eyeglass lenses, medical endoscopes and semiconductor related products, which ties it closely to healthcare and technology demand. In recent years, these areas...
TSE:6432
TSE:6432Machinery

Takeuchi Mfg (TSE:6432) Net Margin Firm At 12.5% Challenges Earnings Decline Narrative

Latest FY 2026 earnings snapshot Takeuchi Mfg (TSE:6432) has wrapped up FY 2026 with fourth quarter revenue of ¥52.5 billion and basic EPS of ¥103.85, capping a year in which trailing twelve month revenue reached ¥225.3 billion and EPS came in at ¥611.92 as earnings grew 8.3% over the last year. The company has seen revenue move from ¥213.2 billion to ¥225.3 billion on a trailing twelve month basis, while EPS tracked from ¥552.44 to ¥611.92, which gives a fuller sense of how the top line and...
TSE:6723
TSE:6723Semiconductor

Assessing Renesas Electronics (TSE:6723) Valuation After Artemis II Radiation‑Hardened IC Milestone

Renesas Electronics (TSE:6723) is in focus after confirming that its Intersil radiation hardened ICs are integrated into key avionics and safety subsystems on NASA’s recently launched Artemis II crewed lunar mission. See our latest analysis for Renesas Electronics. The Artemis II contract arrives at a time when momentum in Renesas Electronics’ shares has been picking up, with a 7 day share price return of 16.95% and a 1 year total shareholder return of 59.16% pointing to growing investor...
TSE:2802
TSE:2802Food

Activist Stake Puts Ajinomoto’s AI Monopoly And Valuation In Focus

An activist investor has built a stake in Ajinomoto, which holds a monopoly on a material used in artificial intelligence infrastructure. The move introduces a new shareholder voice that could influence how the company manages its AI related business and broader capital allocation. Ajinomoto (TSE:2802), trading at ¥4,652.0, has attracted fresh attention after an activist investor took a position in the company. The stock has logged very large 5 year returns, alongside gains of 40.0% year to...
TSE:8591
TSE:8591Diversified Financial

ORIX Hilco Deal Expands Asset Lending And Highlights Valuation Debate

ORIX Corporation USA has acquired a majority stake in Hilco Global. The deal is driving the launch of an expanded asset-based lending platform that combines ORIX capital with Hilco asset expertise. The new platform is intended to offer more flexible and custom financing solutions across multiple industries. For investors watching ORIX (TSE:8591), this move comes at a time when the share price stands at ¥4,879.0 and the stock has recorded a 221.2% return over 5 years. Recent performance has...
TSE:4503
TSE:4503Pharmaceuticals

Astellas Licenses Dyno Muscle Gene Therapy Capsid And Investors Weigh Upside

Astellas Pharma (TSE:4503) licensed a novel AAV capsid from Dyno Therapeutics, designed for targeted gene therapy delivery to skeletal muscle. This is the first capsid licensed under the Astellas and Dyno collaboration and Dyno's first licensed muscle targeting capsid. The agreement focuses on improving gene therapy delivery and manufacturing efficiency for Astellas's programs. Astellas Pharma, a global pharmaceutical company listed on TSE:4503, has been building out its gene therapy...
TSE:4307
TSE:4307IT

Is Nomura Research Institute (TSE:4307) Pricing Reflect Its Mixed Returns And Rich P/E Ratio?

Investors may be wondering if Nomura Research Institute is trading at a fair price or if the market is missing something in the current share price. The stock last closed at ¥4,511, with returns of 2.2% over 7 days and 3.9% over 30 days, alongside a 25.1% decline year to date and a 12.9% decline over 1 year. The 3 year and 5 year returns stand at 47.0% and 42.4% respectively. These mixed returns have put fresh attention on what is driving sentiment around Nomura Research Institute and...